旭通控股(01826.HK)擬850萬港元出售豐展設計及營造全部權益
格隆匯 10 月 5日丨旭通控股(01826.HK)宣佈,公司直接全資附屬FDB & Associates Limited擬向買方IP Kong Ling先生出售豐展設計及營造全部已發行股本,建議代價為850萬港元,雙方訂立諒解備忘錄。
於公告日期,豐展設計及營造主要從事承包業務及提供樓宇諮詢服務。豐展設計及營造一直進行業務轉讓,以根據業務轉讓協議將承包業務及與承包業務有關的所有資產及負債轉讓予榮利,此後承包業務將保留並繼續由集團經營。於根據業務轉讓協議完成業務轉讓後,豐展設計及營造將主要從事樓宇諮詢服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.